Anti-senescence effects of 4-methoxychalcone and 4-bromo-4'-methoxychalcone on human endothelial cells.

Drug Discov Ther

Centre for Natural Products Research and Drug Discovery, Universiti Malaya, Wilayah Persekutuan Kuala Lumpur, Malaysia.

Published: July 2024

Senolytics are drugs that specifically target senescent cells. Flavonoids such as quercetin and fisetin possess selective senolytic activities. This study aims to investigate if chalcones exhibit anti-senescence activities. Anti-senescence effect of 11 chalcone derivatives on the replicative senescence human aortic endothelial cells (HAEC) and human fetal lung fibroblasts (IMR90) was evaluated. Compound 2 (4-methoxychalcone) and compound 4 (4-bromo-4'-methoxychalcone) demonstrated increased cytotoxicity in senescent HAEC compared to young HAEC, with significant differences on IC values. Their anti-senescence effects on HAEC exceeded fisetin. Higher selectivity of compound 4 toward HAEC over IMR90 could be attributed to 4-methoxy (4-OMe) substitution at ring A (R1). Chalcone derivatives have potentials as senolytics in mitigating replicative senescence, warranting further research and development on chalcones as anti-senescent agent.

Download full-text PDF

Source
http://dx.doi.org/10.5582/ddt.2024.01034DOI Listing

Publication Analysis

Top Keywords

anti-senescence effects
8
endothelial cells
8
chalcone derivatives
8
replicative senescence
8
haec
5
anti-senescence
4
effects 4-methoxychalcone
4
4-methoxychalcone 4-bromo-4'-methoxychalcone
4
4-bromo-4'-methoxychalcone human
4
human endothelial
4

Similar Publications

Cellular senescence is a phenomenon distinguished by the halting of cellular division, typically triggered by DNA injury or numerous stress-inducing factors. Cellular senescence is implicated in various pathological and physiological processes and is a hallmark of aging. The presence of accumulated senescent cells, whether transiently (acute senescence) or persistently (chronic senescence) plays a dual role in various conditions such as natural kidney aging and different kidney disorders.

View Article and Find Full Text PDF

Currently, there is no specific treatment for diabetes-induced osteoporosis (DOP). Our study identified diabetes-induced cellular senescence, marked by elevated activity of senescence-associated β-galactosidase. Targeting senescent cells holds promise for osteoporosis treatment.

View Article and Find Full Text PDF

Nitazoxanide alleviates experimental pulmonary fibrosis by inhibiting the development of cellular senescence.

Life Sci

January 2025

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao. Electronic address:

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by irreversible lung scarring with a poor prognosis. Emerging evidence has revealed that IPF is an aging-related disease, and the development of cellular senescence plays a pivotal role in persistent remodeling and fibrotic scarring, acting as a key mechanism in the pathophysiology of IPF. Exploring therapeutic strategies for modulating cellular senescence can provide crucial insights into unraveling IPF processes.

View Article and Find Full Text PDF

Glis1 inhibits RTEC cellular senescence and renal fibrosis by downregulating histone lactylation in DKD.

Life Sci

January 2025

Department of Nephrology, Daping Hospital, Army Medical University, Chongqing 400042, China; Chongqing Key Laboratory of Precision Diagnosis and Treatment for Kidney Diseases; State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China. Electronic address:

Background: Accelerated senescence of renal tubular epithelial cells (RTEC) is critical in the progression of diabetic kidney disease (DKD). GLIS family zinc finger 1 (Glis1) alleviates age-related renal fibrosis in naturally aged mice. However, the role and associated mechanism of Glis1 in accelerated senescence of RTEC and the development of DKD remain unclear.

View Article and Find Full Text PDF

Chronic high-altitude hypoxia (CHH) induces irreversible abnormalities in various organisms. Emerging evidence indicates that CHH markedly suppresses bone mass and bone strength. Targeting senescent cells and the consequent senescence-associated secretory phenotype (SASP) with senolytics is a recently developed novel therapy for multiple age-related diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!